Friedreich Ataxia Scientific News
Friedreich Ataxia and close related scientific news. Topics related to rare diseases.
Wednesday, July 13, 2022
EE146 Cost and Resource Utilization in Friedreich Ataxia: A Systematic Literature Review
›
R Zhang, K Buesch; Value in Health, Volume 25, Issue 7, Supplement, 2022, Page S363, doi:10.1016/j.jval.2022.04.396. The search retrieved 5...
CO49 Clinical Efficacy and Safety of Therapeutic Interventions Used in Friedreich Ataxia: A Systematic Review
›
P Jain, L Badgujar, JA Spoorendonk, K Buesch; Value in Health, Volume 25, Issue 7, Supplement, 2022, Pages S312-S313, doi:10.1016/j.jval.20...
Natural History of Friedreich's Ataxia: Heterogeneity of Neurological Progression and Consequences for Clinical Trial Design
›
Christian Rummey, Louise A Corben, Martin Delatycki, George Wilmot, Sub H Subramony, Manuela Corti, Khalaf Bushara, Antoine Duquette, Christ...
Tuesday, July 12, 2022
Rare motor disorder: International study investigates living situation of people with Friedreich’s Ataxia
›
AAAS and EurekAlert. NEWS RELEASE 11-JUL-2022 DZNE - GERMAN CENTER FOR NEURODEGENERATIVE DISEASES The study aims to investigate and evaluat...
Monday, July 11, 2022
셀리버리 “올해 코로나19·아토피 2상 진입 기대…무증 적절”
›
[KBIC 2022] 조대웅 대표 발표 프리드리히 운동실조증(FRDA) 치료제 ‘AAV-FXN-aMTD‘는 TSDT를 적용한 세포·조직투과성 aMTD-융합 Frataxin(FXN) 재조합단백질이다. 조 대표는 “현재 다케다 제약과 공동 연구개발을 진...
Sunday, July 10, 2022
HTA decision-making for drugs for rare diseases: comparison of processes across countries
›
Tania Stafinski, Judith Glennie, Andrea Young & Devidas Menon; Orphanet J Rare Dis 17, 258 (2022). doi:10.1186/s13023-022-02397-4 There...
Thursday, July 7, 2022
A Phase 1/2 Study of the Safety and Efficacy of LX2006 Gene Therapy in Participants With Cardiomyopathy Associated With Friedreich's Ataxia
›
ClinicalTrials.gov Identifier: NCT05445323; Sponsor: Lexeo Therapeutics Intervention/treatment: Genetic: Low dose LX2006 Adeno-associated ...
Wednesday, July 6, 2022
Large-scale expansions of Friedreich′s ataxia GAA·TTC repeats in human cells are prevented by LNA-DNA oligonucleotides and PNA oligomers
›
Anastasia Rastokina, Negin Mozafari, Jorge Cebrian, Edvard Smith, Sergei M. Mirkin, Rula Zain; bioRxiv 2022.07.04.498742; doi:10.1101/2022.0...
Tuesday, July 5, 2022
Efficacy of plant extracts against Friedreich’s ataxia
›
Magisetty Obulesu, Plant Extracts in Neurodegenerative Diseases, Academic Press, Chapter 4, Pages 47-60, 2022, doi:10.1016/B978-0-323-95762-...
Sunday, July 3, 2022
Clinical and Molecular Spectrum of Degenerative Cerebellar Ataxia: A Single Centre Study
›
Balakrishnan S, Aggarwal S, Muthulakshmi M, Meena AK, Borgohain R, Mridula KR, Yareeda S, Ranganath P, Dalal A. Neurol India 2022;70:934-42...
‹
›
Home
View web version